![mRNA vaccines for infectious diseases: principles, delivery and clinical translation | Nature Reviews Drug Discovery mRNA vaccines for infectious diseases: principles, delivery and clinical translation | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41573-021-00283-5/MediaObjects/41573_2021_283_Fig1_HTML.png)
mRNA vaccines for infectious diseases: principles, delivery and clinical translation | Nature Reviews Drug Discovery
![Short identical gene sequence in SARS-CoV-2 and a gene sequence patented by Moderna can be found in other organisms; not evidence that virus was engineered - Health Feedback Short identical gene sequence in SARS-CoV-2 and a gene sequence patented by Moderna can be found in other organisms; not evidence that virus was engineered - Health Feedback](https://healthfeedback.org/wp-content/uploads/2022/03/blast-alignment-moderna.png)
Short identical gene sequence in SARS-CoV-2 and a gene sequence patented by Moderna can be found in other organisms; not evidence that virus was engineered - Health Feedback
![Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society](https://pubs.acs.org/cms/10.1021/jacs.1c08484/asset/images/large/ja1c08484_0007.jpeg)
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society
![Vaccines | Free Full-Text | Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines Vaccines | Free Full-Text | Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines](https://www.mdpi.com/vaccines/vaccines-09-00734/article_deploy/html/images/vaccines-09-00734-g001-550.jpg)
Vaccines | Free Full-Text | Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines
![Anaphylaxis after Moderna COVID-19 vaccine - Jeremy Mayfield, Sumedha Bandi, Latha Ganti, Jose Rubero, 2021 Anaphylaxis after Moderna COVID-19 vaccine - Jeremy Mayfield, Sumedha Bandi, Latha Ganti, Jose Rubero, 2021](https://journals.sagepub.com/cms/10.1177/25151355211048418/asset/images/large/10.1177_25151355211048418-fig1.jpeg)
Anaphylaxis after Moderna COVID-19 vaccine - Jeremy Mayfield, Sumedha Bandi, Latha Ganti, Jose Rubero, 2021
![A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice | Cell Research A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice | Cell Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41422-020-00392-7/MediaObjects/41422_2020_392_Fig1_HTML.png)
A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice | Cell Research
![Moderna on Twitter: "Accelerated research and development timelines are a potential advantage of #mRNA vaccines https://t.co/s51Ex9k6dJ" / Twitter Moderna on Twitter: "Accelerated research and development timelines are a potential advantage of #mRNA vaccines https://t.co/s51Ex9k6dJ" / Twitter](https://pbs.twimg.com/media/EVkGdz5XQAEaT0-.jpg)
Moderna on Twitter: "Accelerated research and development timelines are a potential advantage of #mRNA vaccines https://t.co/s51Ex9k6dJ" / Twitter
![Frontiers | SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants Frontiers | SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants](https://www.frontiersin.org/files/Articles/701501/fimmu-12-701501-HTML/image_m/fimmu-12-701501-g001.jpg)
Frontiers | SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Moderna, Inc. - Dr. Jacqueline Miller, Moderna's SVP, Infectious Diseases Development, is now presenting on the clinical development update of our COVID-19 vaccine candidate, mRNA-1273. https://buff.ly/2RBY69W | Facebook
![University scientists deconstruct Covid-19 vaccines and publish 'recipe' on open web | Coronavirus | The Guardian University scientists deconstruct Covid-19 vaccines and publish 'recipe' on open web | Coronavirus | The Guardian](https://i.guim.co.uk/img/media/69297335a61c806968f93478288b445422a0b58d/0_397_6048_3627/master/6048.jpg?width=1200&height=1200&quality=85&auto=format&fit=crop&s=dbddcd5ec3fc0927827f3bb598611d27)
University scientists deconstruct Covid-19 vaccines and publish 'recipe' on open web | Coronavirus | The Guardian
![CIMB | Free Full-Text | Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line CIMB | Free Full-Text | Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line](https://www.mdpi.com/cimb/cimb-44-00073/article_deploy/html/images/cimb-44-00073-g001.png)